Oppenheimer & Co’s Medallia, Inc. MDLA Stock Holding History

Oppenheimer & Co’s Portfolio MDLA Stock Details MDLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,792	Closed	-$332K	–	1612
2021 Q3	$332K	Sell	9,792 -1,536	-14%	-$51.3K	0.01%	1182
2021 Q2	$382K	Sell	11,328 -5,769	-34%	-$166K	0.01%	1139
2021 Q1	$477K	Sell	17,097 -1,818	-10%	-$67.5K	0.01%	980
2020 Q4	$629K	Sell	18,915 -16,071	-46%	-$512K	0.01%	807
2020 Q3	$959K	Buy	34,986 +22,255	+175%	+$675K	0.02%	600
2020 Q2	$321K	Buy	12,731 +742	+6%	+$17.7K	0.01%	945
2020 Q1	$240K	Buy	+11,989	New	+$322K	0.01%	980

Oppenheimer & Co's MDLA Position: Q4 2021 in Review

Oppenheimer & Co sold out of Medallia, Inc. (MDLA) in Q4 2021, closing a stake of 9,792 shares — an estimated $332K sold.

Oppenheimer & Co first reported a position in MDLA in Q1 2020 and held it in 7 quarters. The position peaked at $959K in Q3 2020. 0 funds tracked by Wall St. Rank hold MDLA as of Q4 2021.

Oppenheimer & Co reported no remaining Medallia, Inc. position as of Q4 2021 after selling out during the quarter.
Oppenheimer & Co sold 9,792 Medallia, Inc. shares in Q4 2021, an estimated $332K.
Oppenheimer & Co first reported a position in Medallia, Inc. in Q1 2020 and held it in 7 quarters.
Oppenheimer & Co's Medallia, Inc. position peaked at $959K in Q3 2020.
0 funds tracked by Wall St. Rank held Medallia, Inc. as of Q4 2021.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.